tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Certara appoints Jon Resnick as CEO, William Feehery to step down December 31
PremiumThe FlyCertara appoints Jon Resnick as CEO, William Feehery to step down December 31
3d ago
FDA guides on streamlined nonclinical monoclonal antibody safety studies
Premium
The Fly
FDA guides on streamlined nonclinical monoclonal antibody safety studies
12d ago
Certara initiated with a Buy at Rothschild & Co Redburn
Premium
The Fly
Certara initiated with a Buy at Rothschild & Co Redburn
23d ago
Certara’s Mixed Performance: Strong Profitability Amidst Service Booking Challenges Leads to Hold Rating
PremiumRatingsCertara’s Mixed Performance: Strong Profitability Amidst Service Booking Challenges Leads to Hold Rating
1M ago
Certara, Inc. Reports Strong Q3 2025 Results
Premium
Company Announcements
Certara, Inc. Reports Strong Q3 2025 Results
1M ago
Certara’s Strong Market Position and Growth Potential Justify Buy Rating
Premium
Ratings
Certara’s Strong Market Position and Growth Potential Justify Buy Rating
1M ago
Certara price target raised to $16 from $15 at KeyBanc
PremiumThe FlyCertara price target raised to $16 from $15 at KeyBanc
2M ago
Certara price target raised to $16 from $14 at Barclays
Premium
The Fly
Certara price target raised to $16 from $14 at Barclays
2M ago
Craig-Hallum bullish on Certara, initiates with a Buy
Premium
The Fly
Craig-Hallum bullish on Certara, initiates with a Buy
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100